Advertisement

Topics

BioLineRx Announces In-licensing of Novel Treatment for Liver Failure Conditions Under ...

07:00 EDT 23 Sep 2016 | BioMedReports - Blog

TEL AVIV, Israel, September 23, 2016/PRNewswire/ --

BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic

Read more...

Original Article: BioLineRx Announces In-licensing of Novel Treatment for Liver Failure Conditions Under ...

NEXT ARTICLE

More From BioPortfolio on "BioLineRx Announces In-licensing of Novel Treatment for Liver Failure Conditions Under ..."

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...